Singapore markets open in 1 minute
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,054.74 +1,400.64 (+2.43%) CMC Crypto 200
1,270.41 -0.34 (-0.03%)
ABT May 2024 104.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:09PM EDT. Market open.
| Previous close | 8.05 |
| Open | N/A |
| Bid | 3.15 |
| Ask | 5.35 |
| Strike | 104.00 |
| Expiry date | 2024-05-24 |
| Day's range | 8.05 - 8.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.